학술논문

Recurrent pterygium treatment using mitomycin C, double amniotic membrane transplantation, and a large conjunctival flap
Document Type
Academic Journal
Source
International Medical Case Reports Journal. Annual, 2018, Vol. 11, p47, 5 p.
Subject
Mitomycin
Surgery
Antineoplastic agents
Astigmatism
Language
English
ISSN
1179-142X
Abstract
Purpose: The aim of this study was to evaluate the clinical outcomes of surgery for recurrent pterygia using mitomycin C (MMC), double amniotic membrane transplantation (AMT), and a large conjunctival flap. Patients and methods: This retrospective case series included 31 eyes in 31 patients with recurrent pterygia. All patients underwent pterygium excision, application of MMC, double AMT, and placement of a large conjunctival flap. Outcome measures were visual acuity, astigmatism, and recurrence. Recurrence was defined as the presence of fibrovascular proliferative tissue crossing the limbus. Results: The patients' mean age was 68.2 years. The mean follow-up period was 3.6 years. The mean preoperative and postoperative best-corrected visual acuities (logMAR conversion) were 0.23 and 0.13, respectively. There was a significant difference between the mean preoperative (-3.85 D) and postoperative (-2.22 D) astigmatism. The recurrence rate was 3.2% (1/31 cases). Conclusion: Surgical pterygium excision with application of MMC, double AMT, and placement of a large conjunctival flap was an effective treatment for recurrent pterygia. Keywords: pterygium, amnion, MMC
Introduction Patients with recurrent pterygia suffer from blurred vision because of the astigmatism. Various surgical procedures have been proposed for treating recurrent pterygia, including conjunctival autografting (CAU), (1,2) conjunctival--limbal autografting [...]